Journal profile · Psychiatry
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
ISSN 1017-7833 · eISSN 1302-9657 · TURKEY · Quarterly · Founded 1990
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY: fully open access; APC about USD 750; review 6–12 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: No longer published by Taylor & Francis Source ↗Publisher website ·
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY's largest topics are Schizophrenia research and treatment, Treatment of Major Depression and Attention Deficit Hyperactivity Disorder, together about 40.4% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
2015 Impact Factor: 0.367 5-year Impact Factor: 0.425 ©Thomson Reuters, Journal Citation Reports® 2016 Psychiatry and Clinical Psychopharmacology (formerly titled Bulletin of Clinical Psychopharmacology) aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology aims to add original studies conducted in Turkey to international scientific knowledge, to encourage original research conducted in Turkey, and to promote the international reputation of Turkish scientists. Psychiatry and Clinical Psychopharmacology publishes high quality research of interest to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry and related sciences. Topics of current interest to clinical, experimental and basic scientists are published in critical subjects, such as psychopharmacology, psychiatry and behavioral science. The journal effectively bridges the gap between basic science and clinical application. Psychiatry and Clinical Psychopharmacology is an Open Access publication, meaning that all content is available to view with no fees, furthering the aim of reaching all interested national and international associations and individuals. Sorry, there are currently no metrics available for this journal.
From the journal's Aims & Scope
Research area (LetPub): Psychiatry
Editor-in-chief Mesut CetinPublisher website
Editorial board by country: none in mainland China; most named Türkiye 38, United States 26, Canada 10, United Kingdom 8, Germany 4 (101 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine23.6%
- Treatment of Major DepressionMedicine10.5%
- Attention Deficit Hyperactivity DisorderMedicine6.3%
- Bipolar Disorder and TreatmentMedicine6.3%
- Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychology5.8%
- Electroconvulsive Therapy StudiesMedicine5.8%
- Substance Abuse Treatment and OutcomesMedicine4.5%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2015
- 0.37Publisher website ·
- 5-year impact factor (publisher)
- 0.43Publisher website ·
- CiteScore 2026-06
- 0.34LetPub ·
- SJR 2026-06
- 0LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 14LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 102OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 582 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 233 |
| 2025 | 0 | 0 | 282 |
| 2024 | 0 | 0 | 336 |
| 2023 | 0 | 0 | 318 |
| 2022 | 0 | 0 | 308 |
| 2021 | 0 | 0 | 374 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | GBP 575 / USD 750 / EUR 665 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Open access publication; all content available to view with no fees. Model summary
Overview Open journals Open Select Dove Medical Press F1000Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Country or region
- TURKEY
- Frequency
- Quarterly
- Founded
- 1990
- ISSN
- 1017-7833
- Electronic ISSN
- 1302-9657
- Latest issue on the website
- Volume 29, Issue 4 (2019)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
How long does peer review take at KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY based?
Of the 101 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Türkiye (38), United States (26) and Canada (10). Counted from the institutions listed on the board page; for reference only.
Is KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY open access, and what is the APC?
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY is a fully open-access journal. APC about USD 750.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .